129 related articles for article (PubMed ID: 22840266)
1. Improving care of women at risk of unsafe abortion: implementing a risk-reduction model at the Uruguayan-Brazilian border.
Fiol V; Briozzo L; Labandera A; Recchi V; Piñeyro M
Int J Gynaecol Obstet; 2012 Sep; 118 Suppl 1():S21-7. PubMed ID: 22840266
[TBL] [Abstract][Full Text] [Related]
2. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion.
Briozzo L; Vidiella G; Rodríguez F; Gorgoroso M; Faúndes A; Pons JE
Int J Gynaecol Obstet; 2006 Nov; 95(2):221-6. PubMed ID: 17010348
[TBL] [Abstract][Full Text] [Related]
3. Implementation of the risk and harm reduction strategy against unsafe abortion in Uruguay: From a university hospital to the entire country.
Labandera A; Gorgoroso M; Briozzo L
Int J Gynaecol Obstet; 2016 Aug; 134 Suppl 1():S7-S11. PubMed ID: 27577026
[TBL] [Abstract][Full Text] [Related]
4. Perceptions of misoprostol among providers and women seeking post-abortion care in Zimbabwe.
Maternowska MC; Mashu A; Moyo P; Withers M; Chipato T
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):16-25. PubMed ID: 25702065
[TBL] [Abstract][Full Text] [Related]
5. Provision of harm-reduction services to limit unsafe abortion in Tanzania.
Kahabuka C; Pembe A; Meglioli A
Int J Gynaecol Obstet; 2017 Feb; 136(2):210-214. PubMed ID: 28099731
[TBL] [Abstract][Full Text] [Related]
6. Complications with use of misoprostol for abortion in Madagascar: between ease of access and lack of information.
Pourette D; Mattern C; Ratovoson R; Raharimalala P
Contraception; 2018 Feb; 97(2):116-121. PubMed ID: 29242087
[TBL] [Abstract][Full Text] [Related]
7. Hidden realities: What women do when they want to terminate an unwanted pregnancy in Bolivia.
Bury L; Aliaga Bruch S; Machicao Barbery X; Garcia Pimentel F
Int J Gynaecol Obstet; 2012 Sep; 118 Suppl 1():S4-9. PubMed ID: 22840269
[TBL] [Abstract][Full Text] [Related]
8. "It is just like having a period with back pain": exploring women's experiences with community-based distribution of misoprostol for early abortion on the Thailand-Burma border.
Tousaw E; Moo SNHG; Arnott G; Foster AM
Contraception; 2018 Feb; 97(2):122-129. PubMed ID: 28780239
[TBL] [Abstract][Full Text] [Related]
9. Unsafe abortion requiring hospital admission in the Eastern Highlands of Papua New Guinea--a descriptive study of women's and health care workers' experiences.
Vallely LM; Homiehombo P; Kelly-Hanku A; Whittaker A
Reprod Health; 2015 Mar; 12():22. PubMed ID: 25889957
[TBL] [Abstract][Full Text] [Related]
10. "We can lose our life for the abortion": exploring the dynamics shaping abortion care in peri-urban Yangon, Myanmar.
Sheehy G; Aung Y; Foster AM
Contraception; 2015 Nov; 92(5):475-81. PubMed ID: 26265443
[TBL] [Abstract][Full Text] [Related]
11. Investigating social consequences of unwanted pregnancy and unsafe abortion in Malawi: the role of stigma.
Levandowski BA; Kalilani-Phiri L; Kachale F; Awah P; Kangaude G; Mhango C
Int J Gynaecol Obstet; 2012 Sep; 118 Suppl 2():S167-71. PubMed ID: 22920622
[TBL] [Abstract][Full Text] [Related]
12. Misoprostol and the politics of abortion in Sri Lanka.
Kumar R
Reprod Health Matters; 2012 Dec; 20(40):166-74. PubMed ID: 23245422
[TBL] [Abstract][Full Text] [Related]
13. How often and under which circumstances do Mexican pharmacy vendors recommend misoprostol to induce an abortion?
Lara D; García SG; Wilson KS; Paz F
Int Perspect Sex Reprod Health; 2011 Jun; 37(2):75-83. PubMed ID: 21757422
[TBL] [Abstract][Full Text] [Related]
14. From risk and harm reduction to decriminalizing abortion: The Uruguayan model for women's rights.
Briozzo L
Int J Gynaecol Obstet; 2016 Aug; 134 Suppl 1():S3-6. PubMed ID: 27577024
[TBL] [Abstract][Full Text] [Related]
15. The biomedicalisation of illegal abortion: the double life of misoprostol in Brazil.
Zordo SD
Hist Cienc Saude Manguinhos; 2016; 23(1):19-36. PubMed ID: 27008072
[TBL] [Abstract][Full Text] [Related]
16. [Cytotec and abortion: the police, the vendors and women].
Diniz D; Madeiro A
Cien Saude Colet; 2012 Jul; 17(7):1795-804. PubMed ID: 22872341
[TBL] [Abstract][Full Text] [Related]
17. Client-pharmacy worker interactions regarding medical abortion in Zambia in 2009 and 2011.
Hendrickson C; Fetters T; Mupeta S; Vwallika B; Djemo P; Raisanen K
Int J Gynaecol Obstet; 2016 Feb; 132(2):214-8. PubMed ID: 26604158
[TBL] [Abstract][Full Text] [Related]
18. The role of medical abortion in the implementation of the law on voluntary termination of pregnancy in Uruguay.
Fiol V; Rieppi L; Aguirre R; Nozar M; Gorgoroso M; Coppola F; Briozzo L
Int J Gynaecol Obstet; 2016 Aug; 134(S1):S12-S15. PubMed ID: 28748589
[TBL] [Abstract][Full Text] [Related]
19. Goals and activities proposed by countries in seven regions of the world toward prevention of unsafe abortion.
Mirembe F; Karanja J; Hassan EO; Faúndes A
Int J Gynaecol Obstet; 2010 Jul; 110 Suppl():S25-9. PubMed ID: 20451201
[TBL] [Abstract][Full Text] [Related]
20. Implementation of the risk and harm reduction strategy against unsafe abortion in Uruguay: From a university hospital to the entire country.
Labandera A; Gorgoroso M; Briozzo L
Int J Gynaecol Obstet; 2016 Aug; 134(S1):S7-S11. PubMed ID: 28748588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
